Global Blood Therapeutics, Inc.
GBTDelisted Oct 5, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001629137
Global Blood Therapeutics, Inc. was delisted on Oct 5, 2022; its insiders filed their last Form 4 on Oct 6, 2022; 247 institutions reported holding it in 13F filings for Q3 2022, worth $4.67B in total; Soros Fund Management was the only superinvestor holding it.
Q1 2023 vs. Q4 2022
How the institutions holding Global Blood Therapeutics, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 2 | 1 | −1 |
| Shares | 622 | 1 | −621 (−99.8%) |
| Value | $42.1K | $68 | −$42.0K (−99.8%) |
New holders (0)
Institutions that held Global Blood Therapeutics, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
None.
Sold out (1)
Institutions that held Global Blood Therapeutics, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Ronald Blue Trust, Inc. | 621 | $42.0K |